News

Damon Runyon Cancer Research Foundation Awards Prestigious Clinical Investigator Award to Two Weill Cornell Medicine Scientists

Two Weill Cornell Medicine scientists have received the Damon Runyon Cancer Research Clinical Investigator Award for 2016 for their innovative research.

The Damon Runyon Cancer Research Foundation bestows these annual awards upon young physician-scientists who are conducting disease-oriented research that demonstrates a high level of innovation and creativity. ...

Anti-Cocaine Vaccine Approved for Clinical Study in People

A vaccine developed at Weill Cornell Medicine and NewYork-Presbyterian to blunt the effects of cocaine has advanced to clinical trials for testing in humans. After demonstrating that the vaccine prevented cocaine from reaching the brain in earlier animal studies, investigators are now enrolling active cocaine addicts in a Phase I randomized control study to test how it works...

We Are Weill Cornell Medicine: New Campaign Celebrates Accomplished, Collaborative Community

At Weill Cornell Medicine, people are the heart and soul of our institution. Our faculty and staff — the physicians, scientists, and administrators who work so hard every day to fulfill our mission to care for patients, discover innovative cures and treatments, and teach the next generation of physicians — make us who we are.

...

Four NYC Medical Centers Receive New NIH Precision Medicine Grant

NEW YORK, NY, July 8, 2016 — Columbia University Medical Center (CUMC) and Weill Cornell Medicine, in collaboration with NewYork-Presbyterian and NYC Health + Hospitals/Harlem, have been awarded a grant from the NIH for approximately $4 million in fiscal year 2016 to enroll participants in the Cohort Program of President Barack Obama's...

Philip Stieg, M.D., Ph.D. and Lewis Cantley , Ph.D.

Not just a shot in the dark

In many ways, it’s a science success story: 8-year-old boy with a rare form of brain cancer is treated by one of the world’s leading experts in the disease, who collaborates with a pioneering precision medicine institute to sequence his cancer and create a first-of-its-kind tumor model replica in the lab, allowing for further analysis and treatment testing without risk of harm to the child.

Upon analysis, the physician-scientist discovers a mutation previously not known to be linked...

New Gene Therapy Protects Against Peanut Allergy

A new gene therapy developed by scientists at Weill Cornell Medicine could eventually prevent the life-threatening effects of peanut allergy with just a single dose, according to a new pre-clinical study.

Peanuts are the most common food that induces fatal or near-fatal reactions in those who are allergic to them, yet preventive treatment is limited. In their study,...

The Leukemia & Lymphoma Society Names John P. Leonard, MD of Weill Cornell Medicine and NewYork-Presbyterian its 2016 Manhattan Light The Night Corporate Chair

The New York City Chapter of The Leukemia & Lymphoma Society (LLS) has announced John P. Leonard, MD, of Weill Cornell Medicine and NewYork-Presbyterian as its 2016 Manhattan Light The Night® corporate chair. Light The Night is LLS's largest annual fundraising event held each fall to find cures...